{"id":10588,"date":"2024-03-31T08:22:53","date_gmt":"2024-03-31T06:22:53","guid":{"rendered":"https:\/\/www.estiv.org\/?page_id=10588"},"modified":"2024-06-06T15:06:58","modified_gmt":"2024-06-06T13:06:58","slug":"calls-for-papers","status":"publish","type":"page","link":"https:\/\/www.estiv.org\/calls-for-papers\/","title":{"rendered":"Calls for papers"},"content":{"rendered":"\n

Join ESTIV’s Mission to Revolutionize Toxicology Research<\/strong><\/p>\n\n\n\n

ESTIV, a leading society committed to advancing New Approach Methodologies (NAMs) in toxicology, is proud of our collaboration with Toxicology in Vitro<\/em> – TIV, Alternatives to Animal Testing – ATLA<\/em>, (ESTIV affiliated Journals) and other forward-thinking journals such as EBT and others. Our goal is to champion the transition from animal testing to more innovative, reliable in vitro and in silico methods. Through these partnerships, we facilitate special issues that spotlight cutting-edge research in the field.<\/p>\n\n\n\n

Explore Recent Calls for Papers<\/strong><\/p>\n\n\n\n

Embrace this opportunity to disseminate your research, contribute to the evolution of toxicology, and engage with a global community of scientists dedicated to ethical and groundbreaking methodologies. Discover our latest calls for papers and how you can contribute to this transformative journey.<\/p>\n\n\n\n

Stay informed, get involved, and help shape the future of toxicology.<\/p>\n\n\n\r\n

\r\n
\r\n
\r\n

TIV: ESTIV 2024 Special Issue: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment<\/h3>\r\n
\r\n
\r\n\r\n
\n

We are thrilled to announce the launch of a Virtual Special Issue (VSI) of ESTIV 2024 in Toxicology in Vitro<\/strong>, dedicated to showcasing the innovative work of scientists in the field of toxicology. This special issue, coded VSI: ESTIV 2024<\/strong>, offers a unique opportunity for researchers attending and presenting at ESTIV 2024 to publish their findings in a prestigious journal.<\/p>\n

Please ensure your manuscript adheres to the submission guidelines of Toxicology in Vitro. Submit your paper through the journal’s submission system and include the code VSI: ESTIV 2024 in your submission.<\/p>\n

Guest editors:<\/strong><\/p>\n<\/div>\n

Dr. Helena Kandarova, Centre of Experimental Medicine Slovak Academy of Sciences, Bratislava, Slovakia
\n<\/em>helena.kandarova@savba.sk<\/a><\/p>\n

Dr. Mark\u00e9ta Dvo\u0159\u00e1kov\u00e1, National Institute of Public Health, Prague, Czech Republic
\n<\/em>marketa.dvorakova@szu.cz<\/a><\/p>\n

Dr. Benoit Maisonneuve, The University of Queensland, Brisbane, Queensland, Australia
\n<\/em>benoit.maisonneuve@netri.com\u00a0<\/a><\/p>\n

 <\/p>\n

Manuscript submission information:<\/strong><\/p>\n

This special issue is invite only for the attendees of the 22nd International Congress on In Vitro Toxicology (ESTIV 2024).Submit your papers via the\u00a0TIV\u00a0submission portal and as Article type select\u00a0VSI:\u00a0ESTIV\u00a02024
\nhttps:\/\/www.sciencedirect.com\/journal\/toxicology-in-vitro\/about\/call-for-papers
\n<\/strong><\/p>\n

Submission deadline: <\/strong>03 November 2024<\/span><\/p>\n\r\n\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n\r\n

\r\n

ATLA: Virtual Special Collection on Serum-free approaches<\/h3>\r\n
\r\n
\r\n\r\n

ATLA<\/em> is pleased to introduce this online special collection of papers on Serum-free approaches.
\nThis collection comprises papers that either used or discussed serum-free approaches in pursuit of completely animal-free replacement alternatives.<\/p>\n

Already published papers in this VSI:\u00a0<\/strong><\/p>\n

Addressing animal welfare issues in fetal blood collection for fetal bovine serum production.<\/a>
\nT McCann and C Treasure; August 2022; 50: 365\u2013368.<\/p>\n

Case studies exemplifying the transition to animal component-free cell culture.<\/a>
\nT Weber, J Wiest, S Oredsson and K Bieback; August 2022; 50: 330\u2013338.<\/p>\n

An evaluation of different types of peptone as partial substitutes for animal-derived serum in Vero cell culture.<\/a>
\nC Lezin, P Mauduit, G Uzan and M Essameldin Abdelgawad; 2022; September 50: 339\u2013348.<\/p>\n

Guest Editor:<\/strong><\/p>\n

Dr. Helena Kan\u010f\u00e1rov\u00e1, CEM SAS, Bratislava Slovakia
\n<\/em>helena.kandarova@savba.sk<\/a><\/p>\n

Manuscript submission information:\u00a0<\/strong><\/p>\n

The VSI is open for submission of papers and there is no deadline. Submit your paper via\u00a0 SAGE submission portal: https:\/\/journals.sagepub.com\/author-instructions\/ATL and indicate a Special issue.<\/p>\n

<\/p>\n

<\/p>\n

<\/p>\n\r\n\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n\r\n

\r\n

EBT: Preregistration templates for toxicology and environmental health research<\/h3>\r\n
\r\n
\r\n\r\n

This Special Issue is a joint effort between Evidence-Based Toxicology and the\u00a0Center for Open Science, to support improvement in research by promoting the preregistration of scientific studies.<\/p>\n

We will consider for the Special Issue any type of preregistration template in any suitable format, so long as it can be applied in the fields of toxicology or environmental health and it adheres to EBT\u2019s submission guidelines around open data standards and the principles of evidence-based toxicology.<\/p>\n

Submissions may include templates for new alternative methods (NAMs), animal studies, and human observational research, for both primary studies and secondary study designs such as systematic evidence maps and systematic reviews.<\/p>\n

Preregistration Templates will continue to be a submission type for Evidence-Based Toxicology after the Special Issue closes, the articles will just not be published as part of the Special Issue or be eligible for the prize for Best Preregistration Template.<\/p>\n

Guest Editor: <\/strong><\/p>\n

\n

Dr Paul Whaley,\u00a0Lancaster University and the Evidence-Based Toxicology Collaboration<\/em>
\np.whaley@lancaster.ac.uk<\/a><\/p>\n

Dr Olwenn Martin,\u00a0University College London<\/em>
\nolwenn.martin@ucl.ac.uk<\/a><\/p>\n<\/div>\n

Read more about the Special Issue here:\u00a0https:\/\/think.taylorandfrancis.com\/special_issues\/preregistration-templates\/<\/a><\/p>\n\r\n\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n\r\n

\r\n

ATLA: Virtual Special Collection on In silico tools<\/h3>\r\n
\r\n
\r\n\r\n
\n

<\/h2>\n<\/div>\n
\n

ATLA is pleased to introduce this online special collection of papers. This collection comprises previously published papers that provide an overview of the latest research on the development and application of in\u00a0silico tools as animal alternatives.
\nAlready published papers in this VSI:\u00a0<\/strong><\/p>\n

A review of\u00a0in silico<\/em>\u00a0tools as alternatives to animal testing: Principles, resources and applications.<\/a>
\nJC Madden, SJ Enoch, A Paini and MTD Cronin. October\u00a02020; 48: 146\u2013172.<\/p>\n

Prediction of human lethal doses and concentrations of MEIC chemicals from rodent LD50\u00a0values: An attempt to make some reparation.<\/a>
\nJ Dearden and M Hewitt; 2021; February\u00a049: 10\u201321.<\/p>\n

The use of\u00a0in silico<\/em>\u00a0tools for the toxicity prediction of potential inhibitors of SARS-CoV-2.<\/a>
\nV Bhat and J Chatterjee; April\u00a02021; 49: 22\u201332.<\/p>\n

Curated data in \u2014 Trustworthy\u00a0in silico<\/em>\u00a0models out: The impact of data quality on the reliability of Artificial Intelligence models as alternatives to animal testing.<\/a>
\nVM Alves, SS Auerbach, N Kleinstreuer, et al; July\u00a02021; 49: 73\u201382.<\/p>\n

A systematic review of published physiologically-based kinetic models and an assessment of their chemical space coverage.<\/a>
\nCV Thompson, JW Firman, MR Goldsmith, et al; November 2021; 49: 197\u2013208.<\/p>\n

Extension of the virtual cell based assay from a 2-D to a 3-D cell culture model.<\/a>
\nE Bednarczyk, Y Lu, A Paini, et al; March 2022; 50: 45\u201356.<\/p>\n

The VEGAHUB platform: The philosophy and the tools.<\/a>
\nA Roncaglioni, A Lombardo and E Benfenati; April\u00a02022; 50: 121\u2013135<\/p>\n

In silico<\/em>\u00a0prediction of human clinical pharmacokinetics with ANDROMEDA by Prosilico: Predictions for an established benchmarking data set, a modern small drug data set, and a comparison with laboratory methods.<\/a>
\nU Fagerholm, S Hellberg, J Alvarsson, and O Spjuth; December 2023; 51: 39\u201354.<\/p>\n

In silico<\/em>\u00a0prediction of eye-irritation using Hansen Solubility Parameters and predicted pKa values.<\/a>
\nM Andersson, U Norinder, S Chavan and I Cotgreave; May 2023;51:204-209<\/p>\n

Guest Editor:<\/strong><\/p>\n

Edited by Prof. Judith Madden, Liverpool John Moores University,UK<\/em>
\n<\/span>J.C.Madden@ljmu.ac.uk<\/a><\/p>\n

Manuscript submission information:\u00a0<\/strong><\/p>\n

The VSI is open for submission of papers and there is no deadline. Submit your paper via\u00a0 SAGE submission portal: https:\/\/journals.sagepub.com\/author-instructions\/ATL<\/a>\u00a0and indicate a Special issue.<\/p>\n<\/div>\n\r\n\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n\r\n

\r\n

ATLA: Virtual Special Collection on Education and training resources<\/h3>\r\n
\r\n
\r\n\r\n
\n

Virtual Special Collection on Education and training resources<\/h2>\n<\/div>\n
ATLA<\/em>\u00a0is pleased to introduce this online special collection of papers. Edited by Susan Trigwell, this collection comprises previously published papers that highlight current educational and training initiatives that promote the use and development of non-animal approaches<\/p>\n

Already published papers in this VSI:\u00a0<\/strong>
\nHow to foster \u2018new approach methodology\u2019 toxicologists.<\/a>
\nT Doktorova, P Azzi, J Hofer, et al; February, 2022; 50: 71\u201375<\/p>\n

Towards more human and humane testing: The role of the device supplier industry.<\/a>
\nK Cuanolo-Contreras and D Benkmann; February 2022; 50: 62\u201370<\/p>\n

Adapting to changes in publishing when searching for alternatives and reporting on animal research: A librarian\u2019s perspective.<\/a>
\nM Ratajeski and RS Miller; February 2022; 50: 57\u201361<\/p>\n

Editor:<\/strong><\/p>\n

Dr.Susan Trigwell, Frame, UK, Managing Editor of ATLA<\/em>
\nsusan@frame.org.uk<\/a><\/p>\n

<\/span>Manuscript submission information:\u00a0<\/strong><\/p>\n

The VSI is open for submission of papers and there is no deadline. Submit your paper via\u00a0 SAGE submission portal:\u00a0https:\/\/journals.sagepub.com\/author-instructions\/ATL<\/a> and indicate a Special issue.<\/p>\n<\/div>\n\r\n\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n\r\n <\/div>\r\n<\/div>\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Join ESTIV’s Mission to Revolutionize Toxicology Research ESTIV, a leading society committed to advancing New Approach Methodologies (NAMs) in toxicology,…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":13,"ping_status":"closed","template":"","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","_searchwp_excluded":"","_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[0],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_core_expirator_enabled":"","_core_expirator_date":"","_yoast_wpseo_redirect":"","rank_math_redirect":"","redirect":"","_core_expirator_redirect_url":"","footnotes":""},"class_list":["post-10588","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/10588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/users\/3"}],"version-history":[{"count":19,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/10588\/revisions"}],"predecessor-version":[{"id":11483,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/10588\/revisions\/11483"}],"wp:attachment":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/media?parent=10588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}